Personal Profile
He was awarded a Clinical Research Fellowship with The Imperial Cancer Research Fund (Hammersmith Hospital).
In 2002 he obtained a PhD from Imperial College researching in the field of gene transcription and cancer. He completed training in medical oncology at The Royal Marsden Hospital and was awarded an ASCO Foundation Merit Award in 2005 before being appointed Consultant Medical Oncologist at the Kent Oncology Centre in 2006.
He specialises in the treatment of thoracic and gastrointestinal cancers including unknown primary and acute oncology. Dr Shah works within several multidisciplinary teams (lung, colorectal and upper GI) and ensures all private patients benefit from specialist discussions within these groups (including thoracic surgeons, hepatobiliary surgeons, colorectal surgeons, clinical oncologists, gastroenterologists, respiratory physicians, histopathologists, radiologists and clinical nurse specialists).
He is an active clinical researcher and acts as principal investigator on a range of clinical trials within the national portfolio as well as being involved in phase II/III clinical trials of novel agents (e.g. BTOG2, LUNGSTAR, ET, MOLMED, MAGRIT, LuxLung 3, LuxLung5, ARCHER, ST03, ESPAC4, SCOT, JMIK).
